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Abstract 
Thioureas are important sulfur and nitrogen containing compounds and they are useful substances in drug research. In an 
effort to improve potential anticancer activities, two novel 1-benzoyl-3-methyl thiourea derivatives were designed and 
synthesized with substitution at aromatic positions of C-3, and C-4 of 1-benzoyl-3-methyl thiourea. Their structures were 
confirmed using IR, MS and 1H-NMR. The in vitro cytotoxicity against HeLa cell lines were evaluated by the standard MTT 
assay. All of the compounds exhibited more potent cytotoxicity with IC50 values of 160–383 Pg/mL stronger than 
hydroxyurea with IC50 value of 428 Pg/mL.  
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1. Introduction  
Cancer is one of the major causes of death in developing countries and also in the worldwide. In Indonesia, the 
cancer became the third largest contributor to death after heart disease. Since 2007 breast cancer reached first 
ranks for in-patients in hospitals, followed by cervical cancer1. It is still ongoing efforts to find new anticancer 
drugs because long used drugs have gradually become less effective and there is a tendency of resistance2. 
Thiourea is an organic compound that has carbon, nitrogen, sulfur and hydrogen group. This compound is similar 
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to urea except that the oxygen atom is replaced by sulfur. Thiourea and its derivatives appear as white, lustrous 
crystal or flaky solids and they are useful in pharmaceuticals3. From some previous studies have observed that 
thiourea derivatives have potent pharmacological activities such as anti-HIV/antivirus4, analgesic5 and anticancer 
properties6,7,8.  
In previous studies, we have studied the interaction between 1-benzoyl-3-methylthiourea compound and 
COX-29. We have also synthesized and characterized 1-benzoyl-3-methylthiourea10. In other study, we have 
synthesized and in vitro test of 1-benzoil-3-phenylthiourea compound in MCF-7 cells and 1-benzoyl-3-
phenylthiourea compound have IC50 value in MCF-7 cells at 245 Pg/mL11.  
In order to find more potent thiourea anticancer agents, we modified the thiourea structure by attached one 
methyl group and substituted aromatic ring on the one N-atom generated some 1-benzoyl-3-methylthiourea 
derivatives. The anticancer activity of the new compounds were evaluated against HeLa cancer cell line. 
2. Materials and Methods 
 
2.1. Materials 
 
The 1-benzoyl-3-methylthiourea (3a-c) were synthesized from the reaction of starting material N-
Methylthiourea (2) with several ring-substituted benzoyl chlorides (1) (Figure 1). The structure of synthesized 
compound were identified by IR, 1H-NMR, 13C-NMR, and MS spectroscopy; whereas their purity were 
determined by melting point and TLC analysis.  
 
 
 
 
 
 
 
 
 
 
Fig. 1. Scheme of synthesis reaction of the 1-benzoyl-3-methylthioureas 
 
2.2. General Experimental 
 
All reagents and solvents were purchased from standard commercial suppliers. Melting points were measured 
with an electrothermal melting point apparatus without correction. IR spectra were recorded in KBr on Jasco FT-
IR 5300 and major absorption was listed in cm-1. 1H-NMR spectra were taken at Agilent 500 MHz spectrometer, 
and chemical shift were reported in ppm on the G-scale from internal standard TMS. MS spectra were measured 
with Agilent 6890N spectrometer using EI methods. TLC was carried out on aluminium plates coated with silica 
gel F254 (Merck) using UV lamp 254 nm to spot detection. 
 
2.3. Synthesis of 1-Benzoyl-3-Methylthiourea derivatives 
 
To 0.05 mol N-Methylthiourea in tetrahydrofuran (THF) and triethylamine and then a few drops of 0.025 mol 
benzoyl chloride were added slowly at room temperature. Then the temperature was raised to 100 0C and the 
mixture were refluxed for 5 hours. The mixture was concentrated by evaporating THF and the product was 
washed with water and saturated sodium bicarbonate respectively. The resulting solid was recrystalised from hot 
ethanol to give 1-benzoyl-3-methylthiourea compounds 3a-c (Figure 1).  
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2.4. Anticancer Activity 
 
In vitro anticancer activity against HeLa cancer cell lines was assayed by MTT method and expressed in IC50 
value, concentration of the compounds inducing a 50% inhibition of cell growth of treated cells compared to the 
growth of control cells. Hydroxyurea (HU) was used as the reference drug. Cancer cell lines were seeded at a 
density of 1x104 cells/well in 96-well microplates. After 24 hours, exponentially growing cells were exposed to 
the test compounds in DMSO at final concentration ranging from 15.625 to 250 Pg/mL. After 48 hours incubated 
in a 5% CO2 incubator at 37 
0C, cell survival was determined by the addition of MTT solution (100 μL of 0.5 
mg/ml MTT in PBS). Once formazan was formed, 100 μL 10% SDS in 0.1 N HCl was added and plates were 
incubated in the dark at 37 0C overnight. The absorbance was observed at 595 nm  on ELISA-reader and survival 
ratio of living cells were exppressed in percentages with respect to untreated cells. Each experiment was 
performed at least three times. The IC50 value of the test compounds were shown in Table 1. 
 
 
3. Results and Discussions 
 
3.1. Synthesis of 1-Benzoyl-3-Methylthiourea derivatives 
 
Three 1-Benzoyl-3-Methylthiourea derivatives (3a-c) were synthesized from N-Methylthiourea and benzoyl 
chloride in one steps. Two compounds are white solids (3a and 3b), one compound is light yellow (3c) and all of 
them are water insoluble substances. The structure of the synthesized compounds were identified by IR, 1H-NMR 
and MS spectroscopy as follows : 
 
3.2. 1-Benzoyl-3-methylthiourea (3a).  
 
 Yield 54% as white crystal, m.p. 96-97 0C. 1H-NMR (CDCl3, 500 MHz): 3.23-3.24 (3H, d, J=5 Hz, CH3), 
7.47-7.50 (2H, t, J=15, H-Ar), 7.59-7.62 (1H, t, J=15, H-Ar), 7.82-7.83 (2H, dd, J=5, 6.5 Hz H-Ar), 9.18 (1H, s, 
NH), 10.7 (1H, s, NH). IR (KBr), Qmax (cm-1) : 3243 (N–H), 1666 (C=O amide), 1565  (C=C Ar), 1195  (-C=S). 
MS m/z EI : 195 (M+), Calculated Mass C9H10N2OS: 194.05. 
 
3.3.  1-(3-Chlorobenzoyl-3-methylthiourea (3b) 
 
 Yield 27% as white crystal, m.p. 65-67 0C. 1H-NMR (CDCl3, 500 MHz): 3.23-3.24 (3H, d, J=5 Hz, CH3), 
7.47-7.50 (2H, t, J=15, H-Ar), 7.59-7.62 (1H, t, J=15, H-Ar), 7.82-7.83 (2H, dd, J=5, 6.5 H-Ar), 9.18 (1H, s, 
NH), 10.7 (1H, s, NH). IR (KBr), Qmax (cm-1) : 3386 (N–H), 1666 (C=O amide), 1581 (C=C Ar), 1172  (-C=S). 
MS m/z EI : 229 (M+), Calculated Mass C9H9ClN2OS: 228.01. 
 
3.3.  1-(4-Nitrobenzoyl-3-methylthiourea (3c).  
 
 Yield 27% as white crystal, m.p. 165-166 0C. 1H-NMR (CDCl3, 500 MHz): 3.24-3.25 (3H, d, J=5 Hz, CH3), 
7.57-7.59 (3H, m, J=9, H-Ar), 7.84 (1H, s, H-Ar); 9.25 (1H, s, NH), 10.20 (1H, s, NH). IR (KBr), Qmax (cm-1) : 
3255 (N–H), 1646(C=O amide), 1562 (C=C Ar), 1052 (-C=S). MS m/z EI: 240 (M+), Calculated Mass 
C9H3N3O3S: 239.04. 
 
The 1-benzoyl-3-methylthiourea was produced by nucleophilic acylation between benzoyl chlorides and N-
Methylthiourea, where the nucleophile was N-Methylthiourea. The structural change of (2) to 1-benzoyl-3-
methylthioureas  was characterized by the conversion of –NH2 moeity of N-Methylthiourea to –N–C=O(Ar). It 
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could be observed in 1H-NMR spectra which showed proton peak at –NH region, and supported by IR spectra 
with N-H bands. The characteristic Q (N-H) stretching vibrations of 1-benzoyl-3-methylthiourea derivatives are 
appeared in the 3243-3386 cm-1. This difference between the Q (N-H) stretching frequencies is due to 
intramolecular hydrogen bonding12. The strong absorption of Q (C=O) amide band in the IR spectra of the 
compounds are observed in the region 1646-1666 cm-1, apparently decreasing in frequencies comparing with the 
ordinary carbonyl absorption (1700 cm-1). This is interpreted as being a result of its conjugated resonance with 
phenyl ring and the possible formation of intramolecular hydrogen bonding with N-H. The frequencies of 1052-
1195 cm-1 are assigned to the Q (C=S) vibration for all compounds respectively. In addition to the infra red 
spectrum, the synthesized compounds have also been confirmed by 1H-NMR and MS.  
 
3.4. Anticancer Activity 
 
Intending to find anticancer agent for cervical cancer, we examined anticancer activity of the compounds in 
vitro on HeLa cell line. The results were listed in Table 1. 
 
Table 1. IC50 in vitro cytotoxicity of the tested compounds against HeLa Cell line. 
Compounds IC50 cytotoxicity (Pg/mL) 
3a 
3b 
3c 
Hydroxyurea (HU) 
383 
363 
160 
428 
 
Table 1 show that all of the tested compounds have IC50 lower than anticancer drug hydroxyurea. Those 
indicated that all of the tested compounds had anticancer activity against HeLa cells higher than HU. It seems 
that benzoyl and methyl group on the structure of thiourea may increase anticancer activity. HU that does not 
contain benzoyl substituents. Compound without substituent on benzene ring (3a) showed the lowest activity 
among the synthesized compounds. 
Compound with nitro substituents on the paraposition (3c) exhibit the highest activity with IC50 of 160 Pg/mL 
and this compound more active than HU with IC50 of 428 Pg/mL. Electron withdrawing atom substitution such as 
chloro at the metaposition and electron-repelling such as nitro at the paraposition of the aromatic ring in the 
compound structure increases the lipophilicity of molecules and is responsible for enhanced cytotoxicity in MTT 
model13. These results indicated that the 1-Benzoyl-3-methylthiourea derivatives were potential as anticancer 
agents against HeLa cell line. However, the mechanism of thiourea toxicity to HeLa cells is not fully understood.  
 
 
Conclusions 
 
The research concluded that three derivatives of 1-Benzoyl-3-methylthiourea showed in vitro anticancer 
activity against HeLa cell line higher than  hydroxyurea. One of them (1-(4-Nitrobenzoyl-3-methylthiourea 
compound-3c) displayed the highest activity among the tested compounds with IC50 160 Pg/mL higher than 
hydroxyurea with IC50 value of 428 Pg/mL. 
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